Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Med. infant ; 25(1): 38-45, marzo 2018. tab
Article in Spanish | LILACS | ID: biblio-883660

ABSTRACT

Son ampliamente conocidos por los pediatras los procedimientos a seguir ante las heridas inflingidas a un niño por perros, gatos o por otros seres humanos. En esta actualización se detallan los microorganismos causales de infecciones posteriores a mordeduras, enfatizando aquellos vinculados a agresiones de otros animales. En casos de mordeduras por animales de granja, salvajes (en especial reptiles) y acuáticos es necesario considerar la inclusión, en el esquema profiláctico empírico inicial, antibióticos activos frente a enterobacterias, Aeromonas, Vibrio y Pseudomonas. En el caso de mordeduras de monos se debe tener en cuenta la posibilidad de infecciones virales potencialmente fatales, en las provocadas por roedores, la esporotricosis y en las producidas por animales acuáticos, las micobacterias atípicas como Mycobacterium marinum o Mycobacterium haemophilum, dado que desarrollan en medios para micobacterias pero a 30ºC (AU)


The adequate procedures to follow in children with bite wounds inflicted by dogs, cats, or by other human beings are well known by pediatricians. This update describes microorganisms that may cause infections in bite wounds, with a focus on those caused by other animals. In bite injuries caused by farm, wild (especially reptiles), and aquatic animals, antibiotics effective against Enterobacteriaceae, Aeromonas, Vibrio, and Pseudomonas should be included in the initial empirical prophylactic treatment scheme. In case of bite injuries caused by monkeys, the possibility of potentially fatal viral infections should be taken into account, in the case of bites by rodents the possibility of sporotricosis should be considered, and in bite wounds inflicted by aquatic animals atypical mycobacteria, such as Mycobacterium marinum or Mycobacterium haemophilum, should be taken into account as they develop in an environment for mycobacteria, but at 30ºC (AU)


Subject(s)
Humans , Anti-Bacterial Agents/therapeutic use , Bites and Stings/epidemiology , Bites and Stings/microbiology , Bites and Stings/mortality , Bites, Human
2.
Med. infant ; 20(1): 13-16, mar. 2013. tab
Article in Spanish | LILACS | ID: lil-774403

ABSTRACT

Kingella kingae es un agente causal de infecciones osteoarticulares especialmente en niños menores de 4 años. En este trabajo se ha realizado un estudio comparativo entre un método molecular [reacción en cadena de la polimerasa (PCR) en tiempo real y dos métodos microbiológicos habitualmente empleados para el estudio de las infecciones osteoarticulares. Sólo se obtuvo resultado positivo para K. kingae por el método de PCR en 3 de las 60 muestras analizadas. Los pacientes evolucionaron sin secuelas aparentes con tratamiento antibiótico. Es importante destacar, como ya lo han hecho otros autores, que adicionando métodos moleculares se puede aumentar sensiblemente la recuperación de este patógeno.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Arthritis, Infectious/diagnosis , Arthritis, Infectious/etiology , Diagnosis , Discitis/diagnosis , Discitis/etiology , Kingella kingae , Molecular Diagnostic Techniques , Polymerase Chain Reaction , Argentina
3.
Med. infant ; 20(1): 13-16, mar. 2013. tab
Article in Spanish | BINACIS | ID: bin-132569

ABSTRACT

Kingella kingae es un agente causal de infecciones osteoarticulares especialmente en niños menores de 4 años. En este trabajo se ha realizado un estudio comparativo entre un método molecular [reacción en cadena de la polimerasa (PCR) en tiempo real y dos métodos microbiológicos habitualmente empleados para el estudio de las infecciones osteoarticulares. Sólo se obtuvo resultado positivo para K. kingae por el método de PCR en 3 de las 60 muestras analizadas. Los pacientes evolucionaron sin secuelas aparentes con tratamiento antibiótico. Es importante destacar, como ya lo han hecho otros autores, que adicionando métodos moleculares se puede aumentar sensiblemente la recuperación de este patógeno


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Kingella kingae , Molecular Diagnostic Techniques , Diagnosis , Arthritis, Infectious/diagnosis , Arthritis, Infectious/etiology , Polymerase Chain Reaction , Argentina
7.
Rev Argent Microbiol ; 37(2): 78-80, 2005.
Article in Spanish | MEDLINE | ID: mdl-16178460

ABSTRACT

A fatal case of Erysipelothrix rhusiopathiae mitral valve endocarditis is described in a 45 years old male, with a history of chronic alcohol abuse and without animals contact. He presented intermittent fever, polyarthralgia, weight loss, and low back pain. In blood cultures (2 bottles), gram-positive pleomorphic rods grew after 48 hours of incubation. The subculture on blood agar media showed a small, alpha-hemolytic colony, catalase and oxidase negative, PYR and LAP positive and the production of H2S in triple sugar iron agar, was demonstrated. The isolate was initially identified as E. rhusiopathiae, and confirmed by API Coryne (BioMérieux). On the basis of these findings and a transthoracic echocardiogram, an endocarditis was confirmed. Intravenous ampicillin and gentamicin treatment was initiated. The patient became afever, nevertheless he died on day 19 after admission as a consequence of acute pulmonary edema. Susceptibility testing by E-test showed that the microorganism was resistant to vancomycin and gentamicin, and susceptible to penicillin and cefotaxime. We emphasize the importance to consider the isolates of gram-positive pleomorphic rods, catalase and oxidase negative, and the addition of H2S production test in TSI medium. Vancomycin-resistance helps in the identification, and to establish the correct antimicrobial therapy. Although E. rhusiopathiae is usually reported as an occupational pathogen, the contact with pigs and other farm animals may be underestimated.


Subject(s)
Endocarditis, Bacterial/microbiology , Erysipelothrix Infections/microbiology , Erysipelothrix/isolation & purification , Mitral Valve/microbiology , Alcoholism/complications , Ampicillin/therapeutic use , Deafness/complications , Diabetes Mellitus, Type 2/complications , Drug Resistance, Multiple, Bacterial , Drug Therapy, Combination , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/diagnostic imaging , Endocarditis, Bacterial/drug therapy , Erysipelothrix/drug effects , Erysipelothrix Infections/diagnosis , Erysipelothrix Infections/drug therapy , Fatal Outcome , Gentamicins/therapeutic use , Humans , Male , Middle Aged , Mitral Valve/diagnostic imaging , Pulmonary Edema/etiology , Ultrasonography
8.
Rev. argent. microbiol ; 37(2): 78-80, Apr.-June 2005.
Article in Spanish | LILACS-Express | LILACS, BINACIS | ID: biblio-1171751

ABSTRACT

A fatal case of Erysipelothrix rhusiopathiae mitral valve endocarditis is described in a 45 years old male, with a history of chronic alcohol abuse and without animals contact. He presented intermittent fever, polyarthralgia, weight loss, and low back pain. In blood cultures (2 bottles), gram-positive pleomorphic rods grew after 48 hours of incubation. The subculture on blood agar media showed a small, alpha-hemolytic colony, catalase and oxidase negative, PYR and LAP positive and the production of H2S in triple sugar iron agar, was demonstrated. The isolate was initially identified as E. rhusiopathiae, and confirmed by API Coryne (BioMérieux). On the basis of these findings and a transthoracic echocardiogram, an endocarditis was confirmed. Intravenous ampicillin and gentamicin treatment was initiated. The patient became afever, nevertheless he died on day 19 after admission as a consequence of acute pulmonary edema. Susceptibility testing by E-test showed that the microorganism was resistant to vancomycin and gentamicin, and susceptible to penicillin and cefotaxime. We emphasize the importance to consider the isolates of gram-positive pleomorphic rods, catalase and oxidase negative, and the addition of H2S production test in TSI medium. Vancomycin-resistance helps in the identification, and to establish the correct antimicrobial therapy. Although E. rhusiopathiae is usually reported as an occupational pathogen, the contact with pigs and other farm animals may be underestimated.

9.
Rev. argent. microbiol ; 37(2): 78-80, 2005 Apr-Jun.
Article in Spanish | BINACIS | ID: bin-38292

ABSTRACT

A fatal case of Erysipelothrix rhusiopathiae mitral valve endocarditis is described in a 45 years old male, with a history of chronic alcohol abuse and without animals contact. He presented intermittent fever, polyarthralgia, weight loss, and low back pain. In blood cultures (2 bottles), gram-positive pleomorphic rods grew after 48 hours of incubation. The subculture on blood agar media showed a small, alpha-hemolytic colony, catalase and oxidase negative, PYR and LAP positive and the production of H2S in triple sugar iron agar, was demonstrated. The isolate was initially identified as E. rhusiopathiae, and confirmed by API Coryne (BioMérieux). On the basis of these findings and a transthoracic echocardiogram, an endocarditis was confirmed. Intravenous ampicillin and gentamicin treatment was initiated. The patient became afever, nevertheless he died on day 19 after admission as a consequence of acute pulmonary edema. Susceptibility testing by E-test showed that the microorganism was resistant to vancomycin and gentamicin, and susceptible to penicillin and cefotaxime. We emphasize the importance to consider the isolates of gram-positive pleomorphic rods, catalase and oxidase negative, and the addition of H2S production test in TSI medium. Vancomycin-resistance helps in the identification, and to establish the correct antimicrobial therapy. Although E. rhusiopathiae is usually reported as an occupational pathogen, the contact with pigs and other farm animals may be underestimated.

10.
Medicina (B.Aires) ; 64(2): 143-145, 2004. tab
Article in English | LILACS | ID: lil-444341

ABSTRACT

Erythromycin (ERY) resistance in Streptococcus pyogenes has recently emerged as a problem of growing concern all through the world. We are presenting the comparison of results of the continuous surveillance of erythromycin resistance in S. pyogenes performed since 1989 in the Hospital de Pediatría J.P.Garrahan of Buenos Aires City, with independently observed rates in other five centers of Buenos Aires and seven centers of six other Argentinian cities, obtained between 1999 and 2001. A significant increase of erythromycin resistance was observed among S. pyogenes isolated in the Hospital Garrahan (6.6% in 1998-1999 to 9.9% in 2000). Similar trends were also detected in other centers of other Argentinian cities when recent data were compared to results of a multicenter study performed in 1995. However, lower rates of resistance were recorded in Mendoza, Cipolletti and Neuquén in comparison with data of 1995, 1998 and 1998 respectively. The reason of such decreasing resistance rates deserves to be investigated. The average of ERY-resistance rates obtained in the surveyed centers was 6.7% (range 0.5-14.1%). Control of antimicrobial use should be performed to warrant the future effectiveness of macrolide antibiotics regarding the positive association between use and resistance. These results also suggest that susceptibility tests for macrolides should be performed whenever S. pyogenes is isolated in Argentina.


La resistencia a la eritromicina en Streptococcus pyogenes ha emergido en los últimos tiempos como un problema creciente en todo el mundo. En este trabajo se presenta la comparación de los resultados de la vigilancia continua de la resistencia a la eritromicina que se viene realizando en el Hospital de Pediatría J.P.Garrahan de Buenos Aires desde 1989, con resultados independientes de otros cinco centros de la ciudad de Buenos Aires y siete de otras seis ciudades argentinas, obtenidos entre 1999 y 2001. Se observó un aumento significativo en el Hospital Garrahan (6.6% en1998-1999 a 9.9% en el año 2000) y una tendencia similar en otros centros de diversas ciudades argentinas si secomparan estos datos con los de un estudio multicéntrico realizado en 1995. No obstante, se registraron menoresporcentajes de resistencia en Mendoza, Neuquén y Cipolletti, en relación a lo hallado en 1995, 1998 y 1998respectivamente. La razón de esta disminución merece ser investigada. El porcentaje promedio de resistencia aeritromicina obtenido en los distintos centros participantes de este estudio fue de 6.7% (rango 0.5-14.1%). Debeefectuarse un control en el uso de estos antibióticos para garantizar la efectividad futura de los macrólidos, teniendo en cuenta la asociación estrecha entre uso y resistencia. Estos resultados sugieren que deberían realizarse pruebas de sensibilidad a los macrólidos para todos los aislamientos de S. pyogenes en la Argentina.


Subject(s)
Humans , Child , Anti-Bacterial Agents/therapeutic use , Erythromycin/therapeutic use , Streptococcal Infections/drug therapy , Streptococcus pyogenes/drug effects , Argentina , Drug Resistance, Bacterial , Hospitals, Pediatric , Microbial Sensitivity Tests , Multicenter Studies as Topic
11.
Medicina (B.Aires) ; 64(2): 143-145, 2004. tab
Article in English | BINACIS | ID: bin-123264

ABSTRACT

Erythromycin (ERY) resistance in Streptococcus pyogenes has recently emerged as a problem of growing concern all through the world. We are presenting the comparison of results of the continuous surveillance of erythromycin resistance in S. pyogenes performed since 1989 in the Hospital de Pediatría J.P.Garrahan of Buenos Aires City, with independently observed rates in other five centers of Buenos Aires and seven centers of six other Argentinian cities, obtained between 1999 and 2001. A significant increase of erythromycin resistance was observed among S. pyogenes isolated in the Hospital Garrahan (6.6% in 1998-1999 to 9.9% in 2000). Similar trends were also detected in other centers of other Argentinian cities when recent data were compared to results of a multicenter study performed in 1995. However, lower rates of resistance were recorded in Mendoza, Cipolletti and Neuquén in comparison with data of 1995, 1998 and 1998 respectively. The reason of such decreasing resistance rates deserves to be investigated. The average of ERY-resistance rates obtained in the surveyed centers was 6.7% (range 0.5-14.1%). Control of antimicrobial use should be performed to warrant the future effectiveness of macrolide antibiotics regarding the positive association between use and resistance. These results also suggest that susceptibility tests for macrolides should be performed whenever S. pyogenes is isolated in Argentina.(AU)


La resistencia a la eritromicina en Streptococcus pyogenes ha emergido en los últimos tiempos como un problema creciente en todo el mundo. En este trabajo se presenta la comparación de los resultados de la vigilancia continua de la resistencia a la eritromicina que se viene realizando en el Hospital de Pediatría J.P.Garrahan de Buenos Aires desde 1989, con resultados independientes de otros cinco centros de la ciudad de Buenos Aires y siete de otras seis ciudades argentinas, obtenidos entre 1999 y 2001. Se observó un aumento significativo en el Hospital Garrahan (6.6% en1998-1999 a 9.9% en el año 2000) y una tendencia similar en otros centros de diversas ciudades argentinas si secomparan estos datos con los de un estudio multicéntrico realizado en 1995. No obstante, se registraron menoresporcentajes de resistencia en Mendoza, Neuquén y Cipolletti, en relación a lo hallado en 1995, 1998 y 1998respectivamente. La razón de esta disminución merece ser investigada. El porcentaje promedio de resistencia aeritromicina obtenido en los distintos centros participantes de este estudio fue de 6.7% (rango 0.5-14.1%). Debeefectuarse un control en el uso de estos antibióticos para garantizar la efectividad futura de los macrólidos, teniendo en cuenta la asociación estrecha entre uso y resistencia. Estos resultados sugieren que deberían realizarse pruebas de sensibilidad a los macrólidos para todos los aislamientos de S. pyogenes en la Argentina.(AU)


Subject(s)
Humans , Child , Anti-Bacterial Agents/therapeutic use , Erythromycin/therapeutic use , Streptococcal Infections/drug therapy , Streptococcus pyogenes/drug effects , Argentina , Drug Resistance, Bacterial , Hospitals, Pediatric , Microbial Sensitivity Tests , Multicenter Studies as Topic
13.
Medicina (B Aires) ; 60(4): 487-90, 2000.
Article in Spanish | MEDLINE | ID: mdl-11188957

ABSTRACT

Penicillin resistance has not yet been detected in Streptococcus pyogenes. However macrolide-resistant streptococci have emerged in several countries. Only low rates of erythromycin-resistant S. pyogenes were reported in Argentina, with the exception of a 11.1% observed in Mendoza. The aim of the present study was to determine the susceptibility to penicillin and to erythromycin of 251 consecutive clinically-significant isolates of S. pyogenes obtained from four centers of Cipolletti and Neuquén during the period April-December 1998. The double disk test with erythromycin and clindamycin disks was employed as a screening method to detect ERY-resistant streptococci and to determine the phenotype of macrolide resistance. Disk diffusion was also employed for determining penicillin susceptibility. Macrolide-resistant isolates were also tested for penicillin, ceftriaxone, erythromycin, clindamycin and azithromycin susceptibility by the agar dilution method. Additionally they were also tested for erythromycin susceptibility by E-test (AB Biodisk, Solna, Sweden). All streptococci studied were susceptible to penicillin and thirty of them (12.0%) were resistant to erythromycin. All these resistant isolates were also resistant to azithromycin but susceptible to ceftriaxone and clindamycin. They showed the phenotype M (probably efflux-mediated mechanism) and the MICs of erythromycin ranged between 8 and 16 micrograms/ml. According to these results we conclude that in spite of universal susceptibility to penicillin in S. pyogenes, macrolide resistance is a matter of concern in Neuquén and Cipolletti. At least in those cities it appears to be necessary to routinely perform macrolide susceptibility tests in beta-hemolytic streptococci.


Subject(s)
Anti-Bacterial Agents/pharmacology , Erythromycin/pharmacology , Penicillins/pharmacology , Streptococcus pyogenes/drug effects , Argentina , Drug Resistance, Microbial , Penicillin Resistance
14.
Medicina [B Aires] ; 60(4): 487-90, 2000.
Article in Spanish | BINACIS | ID: bin-39672

ABSTRACT

Penicillin resistance has not yet been detected in Streptococcus pyogenes. However macrolide-resistant streptococci have emerged in several countries. Only low rates of erythromycin-resistant S. pyogenes were reported in Argentina, with the exception of a 11.1


observed in Mendoza. The aim of the present study was to determine the susceptibility to penicillin and to erythromycin of 251 consecutive clinically-significant isolates of S. pyogenes obtained from four centers of Cipolletti and Neuquén during the period April-December 1998. The double disk test with erythromycin and clindamycin disks was employed as a screening method to detect ERY-resistant streptococci and to determine the phenotype of macrolide resistance. Disk diffusion was also employed for determining penicillin susceptibility. Macrolide-resistant isolates were also tested for penicillin, ceftriaxone, erythromycin, clindamycin and azithromycin susceptibility by the agar dilution method. Additionally they were also tested for erythromycin susceptibility by E-test (AB Biodisk, Solna, Sweden). All streptococci studied were susceptible to penicillin and thirty of them (12.0


) were resistant to erythromycin. All these resistant isolates were also resistant to azithromycin but susceptible to ceftriaxone and clindamycin. They showed the phenotype M (probably efflux-mediated mechanism) and the MICs of erythromycin ranged between 8 and 16 micrograms/ml. According to these results we conclude that in spite of universal susceptibility to penicillin in S. pyogenes, macrolide resistance is a matter of concern in Neuquén and Cipolletti. At least in those cities it appears to be necessary to routinely perform macrolide susceptibility tests in beta-hemolytic streptococci.

15.
Diagn Microbiol Infect Dis ; 29(1): 29-32, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9350412

ABSTRACT

Two monthly studies on the prevalence of penicillin and erythromycin susceptibility of Streptococcus pyogenes were performed in May and October of 1994 in Argentina. A total of 58 centers from 27 cities participated in these studies. A total of 1072 isolates were tested by a diffusion method, although 595 isolates were tested both by the diffusion and an agar dilution method (n = 1767 isolates). No penicillin-resistant streptococci were found in our study (MIC100 = 0.03 microgram/ml). Only four isolates were confirmed as erythromycin resistant S. pyogenes (prevalence 0.14 and 0.28% in May and October 1994, respectively). Resistance in three isolates was due to an inducible mechanism, although in one strain a different phenotype was observed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Erythromycin/pharmacology , Penicillins/pharmacology , Streptococcus pyogenes/drug effects , Argentina , Drug Resistance, Microbial , Microbial Sensitivity Tests , Penicillin Resistance , Streptococcus pyogenes/metabolism
16.
Chemotherapy ; 41(3): 165-71, 1995.
Article in English | MEDLINE | ID: mdl-7656661

ABSTRACT

Susceptibility to penicillin, vancomycin, imipenem, streptomycin, kanamycin and gentamicin was tested in 130 clinical isolates of Enterococcus spp. by an agar dilution method. Penicillin resistance (MIC > 8 mg/l) was only observed among strains of Enterococcus faecium and Enterococcus raffinosus. Thirty-nine percent of the penicillin-resistant enterococci showed low-level resistance to at least one of the three aminoglycosides tested (gentamicin, kanamycin and streptomycin). Six Enterococcus strains (5 E. faecium and 1 E. raffinosus) with low-level resistance to gentamicin and different MICs for penicillin were tested for antibiotic synergy using time-killing curves. When penicillin concentrations equal to or higher than the MICs were used, synergism was established, even when highly penicillin-resistant strains (MIC > 200 mg/l) were tested. No synergy was observed when penicillin concentrations were below the MICs.


Subject(s)
Anti-Bacterial Agents/pharmacology , Enterococcus/drug effects , Penicillin Resistance , Penicillins/pharmacology , Aminoglycosides , Drug Synergism , Enterococcus/classification , Humans , Microbial Sensitivity Tests , Species Specificity , Vancomycin/pharmacology
20.
Antimicrob Agents Chemother ; 37(8): 1728-9, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8215295

ABSTRACT

Four strains that were moderately susceptible to penicillin and/or ampicillin were found among 54 consecutive isolates of meningococci recovered from patients in one pediatric hospital in Argentina from October 1991 to December 1992. Disk diffusion tests performed with 2 U of penicillin failed to detect one strain. These findings suggest that attention should be paid to changes in the susceptibility patterns of meningococci in order to anticipate therapeutic failures in the future.


Subject(s)
Ampicillin/pharmacology , Neisseria meningitidis/drug effects , Neisseria meningitidis/isolation & purification , Penicillins/pharmacology , Argentina , Humans , Meningitis, Meningococcal/blood , Meningitis, Meningococcal/cerebrospinal fluid , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL